Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

foreignpolicyjournal.com - Ewan Scott - Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Foreign Policy Journal

Income-focused investors in Vistin Pharma ASA (OB: VISTN) have a narrow window remaining to qualify for the Norwegian pharmaceutical company's next dividend payment. The ex-dividend date falls on May 22, meaning any investor who has not settled a…

marketbeat.com - Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
MarketBeat

Commerzbank Aktiengesellschaft FI purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 25,417 shares of the biopharmaceutical…

marketbeat.com - Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
MarketBeat

Qsemble Capital Management LP acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 74,416…

thehindu.com - The Hindu Bureau - HRF alleges unchecked industrial effluent discharge in Anakapalli district
HRF alleges unchecked industrial effluent discharge in Anakapalli district
The Hindu

The Human Rights Forum (HRF) has alleged large-scale discharge of untreated and inadequately treated industrial effluents into water bodies in the Atchutapuram-Rambilli industrial corridor of Anakapalli district, and demanded immediate intervention…

seekingalpha.com - Albert Anthony - Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA)
Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

superpowers4good.com - Chandan Saha - The Great Capital Migration: What 5 Months of Closed Reg CF Campaigns Reveal About the Future of Impact Crowdfunding in 2026
The Great Capital Migration: What 5 Months of Closed Reg CF Campaigns Reveal About the Future of Impact Crowdfunding in 2026
Superpowers for Good

You can advertise in Superpowers for Good. Click to learn more about our affordable options. Over the past five months, the Regulation Impact Crowdfunding ecosystem has demonstrated remarkable resilience and evolution. As we analyze the data from…

globes.co.il - Nitsan Shafir - Tech lawyers return to the fold
Tech lawyers return to the fold
גלובס

Several years ago, law firms reported a trend of lawyers leaving for other companies, taking on in-house legal positions within those companies, and even non-legal roles. The phenomenon was particularly common in tech companies but was also seen in…

marketbeat.com - Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV
Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV
MarketBeat

Millennium Capital Advisors LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 11,875 shares…

marketbeat.com - AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
MarketBeat

WealthPlan Investment Management LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 21.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…

marketbeat.com - AbbVie (NYSE:ABBV) Rating Lowered to Buy at Wall Street Zen
AbbVie (NYSE:ABBV) Rating Lowered to Buy at Wall Street Zen
MarketBeat

AbbVie (NYSE:ABBV - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a report released on Sunday. The Most Important Part of These 3 Big Pharma Earnings Reports Wasn't the Beat…

marketbeat.com - Soltis Investment Advisors LLC Acquires 12,096 Shares of AbbVie Inc. $ABBV
Soltis Investment Advisors LLC Acquires 12,096 Shares of AbbVie Inc. $ABBV
MarketBeat

Soltis Investment Advisors LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 55.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,077 shares of the…

sfstandard.com - Zara Stone - San Francisco startups are pushing a hot peptide summer
San Francisco startups are pushing a hot peptide summer
The San Francisco Standard

By Zara Stone Tech Culture Reporter A few years ago, entrepreneur Julius Ritter was a peptide skeptic. Then he started injecting the compounds regularly into his stomach and backside. Ritter, a blond, brown-eyed 24-year-old with a Clavicular jaw…

marketbeat.com - The Goldman Sachs Group, Inc. $GS Position Increased by May Hill Capital LLC
The Goldman Sachs Group, Inc. $GS Position Increased by May Hill Capital LLC
MarketBeat

May Hill Capital LLC raised its holdings in shares of The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 101.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,402 shares of…

marketbeat.com - L & S Advisors Inc Has $8.01 Million Stake in AbbVie Inc. $ABBV
L & S Advisors Inc Has $8.01 Million Stake in AbbVie Inc. $ABBV
MarketBeat

L & S Advisors Inc lowered its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 18.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,064 shares of the company's…

marketbeat.com - Barr E S & Co. Sells 2,597 Shares of The Goldman Sachs Group, Inc. $GS
Barr E S & Co. Sells 2,597 Shares of The Goldman Sachs Group, Inc. $GS
MarketBeat

Barr E S & Co. lowered its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 146,426…

Receive a Daily briefing on Pharma Industry News

Get Started